Last reviewed · How we verify
Placebo of Pioglitazone — Competitive Intelligence Brief
phase 3
Diabetes
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of Pioglitazone (Placebo of Pioglitazone) — Assistance Publique - Hôpitaux de Paris. This is a placebo control arm in a clinical trial and contains no active pharmaceutical ingredient.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of Pioglitazone TARGET | Placebo of Pioglitazone | Assistance Publique - Hôpitaux de Paris | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of Pioglitazone CI watch — RSS
- Placebo of Pioglitazone CI watch — Atom
- Placebo of Pioglitazone CI watch — JSON
- Placebo of Pioglitazone alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of Pioglitazone — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-pioglitazone. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab